DNTH - Company ID 0001690585
The table below shows Dianthus Therapeutics, Inc. /DE/'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $51.09M | $22.79M | $132.32M | $57.63M | $131.65M | $58.15M |
| Short-term investments | $353.21M | $252.45M | $41.39M | $54.41M | $45.28M | $90.68M |
| Receivables | $52.00K | $807.00K | $294.00K | - | - | - |
| Inventory | - | - | - | - | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $409.44M |
| $280.90M |
| $177.45M |
| $115.60M |
| $180.69M |
| $151.53M |
| Property, plant & equipment | $296.00K | $194.00K | $185.00K | $6.09M | $7.46M | $8.31M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $530.92M | $374.01M | $179.41M | $146.65M | $189.93M | $161.62M |
| Accounts payable | $9.72M | $4.58M | $2.61M | $2.45M | $3.04M | $3.76M |
| Total current liabilities | $30.73M | $18.45M | $9.63M | $14.55M | $10.86M | $11.43M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $37.52M | $21.53M | $10.54M | $40.69M | $17.26M | $17.71M |
| Retained earnings | -$336.73M | -$174.39M | -$89.42M | -$402.03M | -$325.57M | -$254.43M |
| Total equity | $493.40M | $352.48M | $168.87M | $105.96M | $172.67M | $143.91M |